ACI-518

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameACI-518
Drug Alias NameAMPA glutamate receptor agonist (AC Immune)ACI-518
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLomonosov Moscow State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAc Immune Sa
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A